HoldingsChannel.com
| Date | Insider | Price | Amount |
|---|---|---|---|
| 3-21-2024 Insider Buy |
RA CAPITAL MANAGEMENT, L.P. |
$15.03 CAGR » |
$15,000,075.27 998,009 shares |
Also See: Institutional Holders of LENZ
Also See: SEC filings
|
Growth of $10,000.00 With Dividends Reinvested |
|||
| Start date: | 03/22/2024 | ||
| End date: | 05/01/2024 | ||
| Start price/share: | $16.20 | ||
| End price/share: | $15.81 | ||
| Starting shares: | 617.28 | ||
| Ending shares: | 892.01 | ||
| Dividends reinvested/share: | $7.21 | ||
| Total return: | 41.03% | ||
| Annualized Gain: | 374.37% | ||
| Starting investment: | $10,000.00 | ||
| Ending investment: | $14,103.00 | ||
| Years: | 0.11 | ||
|
Growth of $10,000.00 Without Dividends Reinvested |
|||
| Start date: | 03/22/2024 | ||
| End date: | 05/01/2024 | ||
| Start price/share: | $16.20 | ||
| End price/share: | $15.81 | ||
| Dividends collected/share: | $7.21 | ||
| Total return: | 42.10% | ||
| Annualized Gain: | 384.15% | ||
| Starting investment: | $10,000.00 | ||
| Ending investment: | $14,210.00 | ||
| Years: | 0.11 | ||
Lenz Therapeutics Inc New Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Lenz Therapeutics Inc New insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding LENZ
 Free LENZ Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
|
|
|
Other companies seeing insider buying close in time to when the Lenz Therapeutics Inc New Insider Buying occurred are:
Ocuphire Pharma Insider Buying
|
